Can You Lose a Huge Amount in a Month on Mounjaro? (October 2026)

01 · The honest answer

So how much can you realistically lose in a month?

A dramatic loss in a month is not a realistic expectation on Mounjaro, and chasing it can push people towards unsafe choices. The first weeks on 2.5mg are an adjustment phase and losses are usually modest; most measurable progress builds from 5mg onward, month by month.¹

Some people notice appetite change and early loss in week one, others feel little until a higher dose, and both are normal.¹ Early loss includes water weight, so the trend over weeks matters more than any single weigh-in.¹³

The larger numbers you may have seen quoted come from the SURMOUNT-1 trial, where average results were measured at 72 weeks on stepped-up doses, alongside diet and exercise.² They are not a one-month benchmark, and it would be misleading to squeeze them into one.

02 · Your decision

Is Mounjaro still right for you if the first month is slow?

Yes, a slow first month says very little about how you will do overall. Slower early progress does not predict failure, because the dose you respond to may still be ahead of you.² Most people start on the lowest strength so the body can adjust, then step up under prescriber review.

The more useful question is whether you are set up to do well over the coming months: eating in a reduced-calorie pattern, staying active, protecting protein, and attending your reviews. Mounjaro is used alongside a reduced-calorie diet and increased physical activity, not instead of them.¹

If you are comparing your own pace with others, our guides on weight lost in a month and losing weight in the first month cover the early weeks in more detail. When you are ready to start, our weight loss clinic explains the options, and your first 2.5mg Mounjaro pen costs £129.99 with code FIRST40 (standard price £169.99). Prices checked 11 October 2026.

03 · How it works

How Mounjaro works, and why that sets the pace

Mounjaro is the brand name for tirzepatide, a once-weekly injectable prescription medicine made by Eli Lilly. In the UK it is licensed for weight management in adults and for type 2 diabetes. It comes as a pre-filled multi-dose pen, the KwikPen, in strengths from 2.5mg to 15mg.¹

Tirzepatide activates two natural gut-hormone receptors at once: GIP and GLP-1. Together these help regulate appetite, slow how quickly the stomach empties, and improve the way the body responds to insulin.¹ In practice, most people feel fuller sooner and less hungry between meals, which supports a reduced-calorie diet.

That mechanism explains why the medicine does not produce a sudden collapse in weight. Instead it changes appetite and eating patterns, and the weight change follows from eating less over time. If your appetite change is gentle in the early weeks, so is your weight change.

It also explains why the dose matters. Starting on 2.5mg and stepping up is how the licence builds the dose gradually, depending on how you respond and tolerate it. The starter pen is there so your body can get used to the medicine, not to drive the largest possible effect in week one.

Think of the first month as laying foundations. You are learning when the appetite effect is strongest after your weekly injection, which foods sit comfortably, how much protein you are getting, and how to keep moving. Those habits do far more for the next several months than any dramatic first-month number.

Because the effect depends on eating less, the biggest lever you control is what you do around the injection. Smaller portions, slower eating and planning meals for when you feel full sooner all help the medicine do its job. Skipping meals entirely is not the aim, and your prescriber can talk through what a sensible intake looks like for you.

If you would like a wider view of how pace builds, our guide to what to expect in the first month sets out the early weeks, and the page on how long larger goals take looks at the longer picture without false precision.

04 · First weeks on 2.5mg

What the first weeks on 2.5mg actually look like

The 2.5mg starting weeks are about adjustment, and experiences differ widely: some people notice appetite change and early loss in week one, others feel little until a higher dose — both are normal.¹ If you feel little at first, that does not mean the medicine is not working or that you have been given the wrong thing.

Early loss includes water weight, so the trend over weeks matters more than any single weigh-in.¹³ Body weight can move up and down within a day because of fluid, food in the gut and salt intake. A sharp first-week drop is therefore not a reliable measure of fat loss, and a flat week is not a failure.

Mild nausea, altered appetite and tiredness in the first days after each injection are the commonest early effects and usually settle.¹³ Plan for this by keeping meals light and regular on injection day and the days after, and by not scheduling anything demanding straight after your dose if you can avoid it.

Practical habits for the starter month:

• Weigh yourself at the same time on the same day each week, and note the trend rather than reacting to one figure.
• Eat protein at each meal so you protect muscle as appetite falls.
• Stay active in ways you enjoy, building up gradually.
• Keep a simple note of appetite, mood and side effects to share at your review.
• Tell your prescriber about any symptom that worries you.

If you notice a side effect, you can report suspected side effects through the Yellow Card scheme.¹⁹ A new symptom is always worth discussing with your prescriber instead of waiting it out.

For a fuller look at the opening weeks, see our page on the first month on treatment. It covers how the starter pen fits into the wider plan, and why a modest start is a normal and expected pattern rather than a warning sign.

One more reassurance: some people lose very little in the first month and still do well later, once they reach the dose that suits them. Comparing your first month with someone else's, particularly someone on a higher dose after switching provider, is rarely a fair comparison.

05 · Dose ladder and pace

Why pace builds as the dose steps up

Weight loss on Mounjaro is gradual by design.¹

A month on the starter pen is therefore only the first rung. The first weeks on 2.5mg are an adjustment phase and losses are usually modest; most measurable progress builds from 5mg onward, month by month.¹ Your dose is not raised to chase a faster scale result; it is raised when it is appropriate for you.

That is also why the pace people describe varies. Someone who has just started on 2.5mg is in a different position from someone who has been stepped up to a higher strength after several months, and someone switching from another provider at a higher dose is different again. Always compare like with like.

Your prescriber decides when to step up, based on how you tolerate the current dose and how you are responding. You should not bring a step-up forward yourself, and a plateau is not a reason to double doses or add unlicensed products.¹

Our page on a longer target over a couple of months explains the same pattern over a longer window, again without false precision.

06 · Trial results in context

What the SURMOUNT-1 results do and do not tell you

In the SURMOUNT-1 trial of 2,539 adults, people taking tirzepatide alongside diet and exercise lost on average 15% of their body weight on 5mg, 19.5% on 10mg and 20.9% on 15mg over 72 weeks, compared with 3.1% with lifestyle changes alone.² These are trial averages, and individual results vary.

The important phrase is over 72 weeks. Those averages describe where groups of people ended up after well over a year of treatment on stepped-up doses, not where they were after four weeks on the starter pen.

Treatment works alongside a reduced-calorie diet and increased physical activity, not instead of them.² The comparison group in the trial also received lifestyle support, which is why the gap between the groups matters.

Averages hide a wide spread. Some people lose more than the average and some less. At 72 weeks, 85% of participants on 5mg, 89% on 10mg and 91% on 15mg had lost at least 5% of their body weight. Half of participants on 10mg and 57% on 15mg lost at least 20% of their body weight.² Those are long-term figures for people who stayed on treatment.

For a three-month view, in SURMOUNT-1 average weight loss built month by month, with the full averages measured at 72 weeks, not 12.² A sensible 3-month expectation on a standard titration is mid single digits as a percentage of body weight, with wide individual variation.

Putting that together, a first month sits well below the three-month picture, which in turn sits well below the long-term trial averages. If your first month looks smaller than something you saw online, you are most likely seeing a normal early pattern, or a result from a different dose, a different starting weight or a different person.

07 · Risks of rushing

Why forcing fast loss is the wrong approach

Trying to force a dramatic first month is more likely to cause problems than results. Mounjaro is a prescription-only medicine supplied after an online consultation reviewed by a GPhC-registered prescriber, and it is used alongside a reduced-calorie diet and increased physical activity.¹ That framing is deliberate: the medicine is a support for steady change, not a crash tool.

• Taking more than prescribed or doubling a dose. A plateau is not a reason to double doses or add unlicensed products. Dose changes are your prescriber's decision.
• Extreme calorie cutting. Eating far too little is not what the medicine is for, and it makes the early nausea and tiredness harder to manage.
• Buying supplements marketed as miracle alternatives. These make dramatic weight-loss claims, are available cheaply without assessment, and their dosing is not standardised.
• Buying pens from sellers offering to supply without a consultation or prescription. The MHRA issues counterfeit medicine alerts, and unsafe supply is a real risk.⁷

Rapid loss in the first days is mostly water, so a quick drop on the scales is not a sign you are safely burning fat faster. It can also reverse, which can be demoralising if you expected it to continue.

If a side effect worries you at any point, speak to your prescriber, and you can report suspected side effects to the Yellow Card scheme.¹⁹ Reporting helps regulators monitor medicines for everyone.

The safest route to a larger change is the dull one: stay on the dose ladder at the pace your prescriber sets, eat in a reduced-calorie pattern, stay active, and keep attending reviews. It takes months, but it is the approach the trials measured.

If you are weighing up how soon to expect visible change, our guide to the first month on Mounjaro sets realistic expectations without pressure to hit an arbitrary number.

08 · Plateaus and slow weeks

Plateaus, slow weeks and what to do about them

Weight loss on Mounjaro is not linear — plateaus of a few weeks are normal and expected as the body adapts to a lower weight.¹ That applies in the first month as much as later, though in month one a flat spell is more often down to the low starter dose.

Within the licence, the responses are specific. Review food intake honestly, because portions drift back up. Protect protein and activity. Check the basics, such as sleep and alcohol. Then discuss with your prescriber whether a dose step-up is appropriate if you are not yet at maximum.¹

It helps to treat a stall as information rather than as a verdict. Ask yourself a few honest questions:

• Have my portion sizes crept up now that appetite feels more normal?
• Am I getting enough protein at each meal?
• Have I been moving less because I feel tired after injections?
• Has alcohol or poor sleep increased?
• Am I weighing at different times of day, which makes the trend noisy?

Tracking helps. Our free GLPTrackr companion app lets you log your journey on iOS or Android, which makes patterns easier to spot and to share with your prescriber at review.

It is also worth remembering that the question you are really asking in a slow week is whether the current dose is doing enough. That is exactly what your prescriber reviews. Your monthly review is the place to raise it, not something to solve by adjusting the pen yourself.

Many people feel a stall most sharply after a dramatic first week. Because early loss includes water weight, the first drop is partly fluid, and what follows is the true pace. Understanding this in advance makes the second and third weeks far easier on morale.

If you want to see how a plateau fits into a wider timeline, our guide on how long bigger goals take covers the long view in a calm, evidence-led way.

09 · Reviews and wider benefits

Prescriber reviews and benefits beyond the scales

Treatment response is reviewed by your prescriber: if you have lost less than 5% of your starting weight after 6 months on the highest dose you can tolerate, your prescriber will discuss whether continuing or stopping is right for you. That review point is measured in months, which again shows why a single month is the wrong yardstick.

Our aftercare includes ongoing monthly reviews, dose-titration and follow-up assessments by the prescribing team, plus side-effect support. Repeat orders re-check suitability, and there is no auto-shipping, so every supply is a considered decision rather than a default.

The scales are only one measure. In trials, weight loss on tirzepatide came with average improvements in waist size, blood pressure, cholesterol and blood-sugar measures, and most participants with prediabetes returned to normal blood-sugar levels.² These are why prescribers talk about weight management as health management rather than appearance.

That wider view is helpful in the first month. Even if the number on the scale has barely moved, you may notice that you feel fuller sooner, snack less, or choose smaller portions. Those behaviour changes are often the earliest signs that the medicine is doing its job, long before the weight shows it.

Useful non-scale signs to watch for include:

• Feeling full on smaller portions.
• Fewer between-meal cravings.
• Clothes feeling slightly different.
• Easier, more comfortable activity.

Record these alongside your weekly weight. Together they give you and your prescriber a fuller picture than a single figure, and they keep motivation steady through the slower early weeks.

Keep in mind that the benefits above are trial averages in groups of people over a long period. They are not a prediction of your own month one, but they are a good reason to keep going patiently rather than judging the treatment on its first few weeks.

10 · Serious side effects

Serious side effects: when to get help straight away

Serious side effects are uncommon but need urgent attention. Seek immediate medical help for: severe, persistent stomach pain that may spread to your back, with or without vomiting (possible pancreatitis); pain in the upper right abdomen, fever or yellowing of skin/eyes (possible gallbladder problems); or signs of a severe allergic reaction such as swelling of the face or throat and difficulty breathing. If you take insulin or a sulfonylurea alongside Mounjaro, watch for low blood sugar (shakiness, sweating, confusion) — your prescriber may need to adjust those medicines.¹

11 · NHS, private and ordering

NHS or private, and how ordering works

Mounjaro is available on the NHS, but access is being phased in over several years. NICE recommends it for adults with a BMI of at least 35 plus at least one weight-related condition, and the NHS primary-care rollout began in June 2025 with the highest-need groups first (initially BMI 40+ with four or more qualifying conditions).⁴⁶ Full rollout is expected to take years, which is why many people who meet the licensed criteria choose regulated private treatment rather than waiting.

Whichever route you choose, the clinical expectations are the same. Pace builds with dose, and the first month on the starter pen is modest. A private prescription does not change the pharmacology, and it does not make the first month faster.

If you choose to order from us, the process is simple:

• Free online consultation. A short health questionnaire, with no charge and no obligation.
• Prescriber review. Reviewed by a GPhC-registered prescriber, not a scoring script. Payment is taken when you place the order; if the prescriber decides the treatment is not suitable, the order is refunded automatically in full.
• Dispensing and delivery. Dispensed by our registered pharmacy, with same-day dispatch when ordered by 3pm and free next-day tracked delivery in temperature-controlled packaging. Saturday delivery is £14.99.

We supply genuine KwikPens through official LillyDirect supply, sourced directly from Eli Lilly. All doses are in stock. We are registered with the GPhC (9012878), which you can check on the public register.¹²

The consultation is free, and the price shown is the price paid. Payment options include Visa, Mastercard, Klarna and pay-monthly plans, with no subscriptions. Needles, a sharps bin and injection guidance come with every order.

You can see current options on the Mounjaro pen page, and our weight loss clinic overview explains how treatment and support fit together. Support is available Monday to Friday, 9am to 5pm, by email, account chat or phone.